Director

Decibel Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Update

Retrieved on: 
Wednesday, November 9, 2022
Disease, Regeneron Pharmaceuticals, Hearing, GLOBE, IND, Update, MHRA, U.S. Securities and Exchange Commission, Food, Congenital hearing loss, Research, File, Medicines and Healthcare products Regulatory Agency, Private Securities Litigation Reform Act, Gene, Development, Sale, GJB2, Board, Spanish Agency of Medicines and Medical Devices, COVID-19, AEMPS, Regulation of tobacco by the U.S. Food and Drug Administration, Therapy, United Kingdom, SEC, Brain, Medicine, Goal, Board of directors, Medical device, Medication, State Administrative Expenses, AAV, Company, Program, Clinical trial, Terminology, Genetic distance, Patient, Ear, CTAS, Security (finance), Administration, FDA, Pharmaceutical industry, Director, Decibel

BOSTON, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today reported financial results for the third quarter ended September 30, 2022 and provided a corporate update.

Key Points: 
  • Decibel continued to maintain strong momentum throughout 2022 as we achieved the goals we set forth for the year.
  • Board of Directors Update: In October 2022, Decibel announced the appointment of Kevin F. McLaughlin to its Board of Directors.
  • Third Quarter 2022 Financial Results:
    Cash Position: As of September 30, 2022, cash, cash equivalents and available-for-sale securities were $111.9 million, compared to $162.3 million as of December 31, 2021.
  • However, while Decibel may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so.

Motorsport Games Announces Completion of Previously Announced 1-for-10 Reverse Stock Split

Retrieved on: 
Wednesday, November 9, 2022
Transfer, GLOBE, Review, Private Securities Litigation Reform Act, Forward-looking statement, State, WST, Motorsport, Director, EST, Special-purpose acquisition company, Intention, LLC, Board, Securities Act of 1933, Class, CUSIP, SEC, Annual report, NASDAQ, Board of directors, Securities Exchange Act of 1934, Time, Company, FIA Motorsport Games, Social media, Delaware General Corporation Law, Security (finance)

Motorsport Games is effecting the reverse stock split by filing a charter amendment with the Delaware Secretary of State.

Key Points: 
  • Motorsport Games is effecting the reverse stock split by filing a charter amendment with the Delaware Secretary of State.
  • The same 1-for-10 reverse stock split ratio is being used to effect the reverse stock split of both Motorsport Games Class A and Class B common stock, and accordingly, all stockholders will be affected proportionately.
  • Motorsport Games has retained its transfer agent, Worldwide Stock Transfer, LLC ("WST"), to act as exchange agent for the reverse stock split.
  • Upon the Effective Time, each certificate, if any representing shares of Motorsport Games common stock immediately prior to the reverse stock split will be deemed to represent the number of full shares of common stock resulting from the reverse stock split.

Michael Peduzzi Appointed to CNB Financial Corporation Board of Directors

Retrieved on: 
Wednesday, November 9, 2022
GLOBE, Director, Board, CCNE, NASDAQ, Retirement, CNB, Trust

CLEARFIELD, Pa., Nov. 09, 2022 (GLOBE NEWSWIRE) -- CNB Financial Corporation (CNB) (NASDAQ: CCNE), the parent company of CNB Bank, announced that Michael Peduzzi, currently the Vice President of CNB and the President and Chief Executive Officer of CNB Bank, was appointed to the Board of Directors of CNB effective January 1, 2023.

Key Points: 
  • CLEARFIELD, Pa., Nov. 09, 2022 (GLOBE NEWSWIRE) -- CNB Financial Corporation (CNB) (NASDAQ: CCNE), the parent company of CNB Bank, announced that Michael Peduzzi, currently the Vice President of CNB and the President and Chief Executive Officer of CNB Bank, was appointed to the Board of Directors of CNB effective January 1, 2023.
  • Mr. Peduzzi was previously appointed to the Board of Directors of CNB Bank and will continue to serve on the Board of Directors of CNB Bank.
  • On November 8, 2022, Mr. Bower informed CNB of his retirement from the Boards of Directors of CNB and CNB Bank, effective December 31, 2022.
  • We are pleased to welcome Mike Peduzzi as a board member, said Peter Smith, Charmain of the Boards of Directors of both CNB and CNB Bank.

STERIS Announces Financial Results for Fiscal 2023 Second Quarter

Retrieved on: 
Wednesday, November 9, 2022
Director, GLOBE, Private Securities Litigation Reform Act, TCJA, Name, Forward-looking statement, STE, Congress, Health care, NYSE, Marketing, Cantel Medical Corporation, Tax Cuts and Jobs Act of 2017, Disclosure, Risk, Literature, Accounting, Health, EPA, Environment, Sale, Board, COVID-19, AST, Legislation, Mission statement, Annual report, Tax, Pressure, Compliance, Time, Company, Steris, Terminology, GAAP, Dental, Growth, Industry, Acquisition, Insurance, FDA, Income, Cryptocurrency, Video game, Health insurance, Bank, Brexit, Customer, EU

DUBLIN, IRELAND, Nov. 09, 2022 (GLOBE NEWSWIRE) --  STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 second quarter ended September 30, 2022. Revenue as reported for the quarter was flat at $1.2 billion compared with $1.2 billion in the second quarter of fiscal 2022. Constant currency organic revenue (see Non-GAAP Financial Measures) increased 7% for the second quarter of fiscal 2023 as compared to the second quarter of fiscal 2022.  

Key Points: 
  • Constant currency organic revenue (see Non-GAAP Financial Measures) increased 7% for the second quarter of fiscal 2023 as compared to the second quarter of fiscal 2022.
  • Adjusted net income (see Non-GAAP Financial Measures) for the second quarter of fiscal 2023 was $199.6 million or $1.99 per diluted share, compared with the previous years second quarter of $200.3 million or $1.99 per diluted share.
  • Operating income was $48.6 million in the second quarter of fiscal 2023 compared with $57.5 million in the prior years second quarter.
  • Operating income was $28.1 million in the second quarter of fiscal 2023 compared with $32.4 million in the prior years second quarter.

Trevena Announces Reverse Stock Split

Retrieved on: 
Wednesday, November 9, 2022
Transfer, Director, GLOBE, Trevena Inc, Nasdaq, Central nervous system disease, Research, Epilepsy, Board, Trevena, CUSIP, Nobel Prize, Exercise, Pain, Migraine, Compliance, Time, Company, Maintenance, Patient, TRV734, Central nervous system, CNS, Pharmaceutical industry, Security (finance), Amendment

The reverse stock split is intended to enable Trevena to regain compliance with the$1.00minimum bid price required for continued listing on the Nasdaq Capital Market.The new CUSIP number for Trevenas common stock following the reverse stock split will be 89532E 208.

Key Points: 
  • The reverse stock split is intended to enable Trevena to regain compliance with the$1.00minimum bid price required for continued listing on the Nasdaq Capital Market.The new CUSIP number for Trevenas common stock following the reverse stock split will be 89532E 208.
  • The reverse stock split will affect all shares of the Companys common stock outstanding immediately prior to the effective time of the reverse stock split, as well as the number of shares of common stock available for issuance under the Companys equity incentive plans.
  • In addition, the reverse stock split will effect a reduction in the number of shares of common stock issuable upon the exercise of stock options and warrants outstanding immediately prior to the effectiveness of the reverse stock split with a corresponding increase in exercise price per share.
  • Stockholders who would otherwise be entitled to receive fractional shares as a result of the reverse stock split will be entitled to a cash payment in lieu thereof at a price equal to the fraction to which the stockholder would otherwise be entitled multiplied by the closing trading price per share of the common stock (as adjusted for the reverse stock split) as reported on The Nasdaq Capital Market on November 9, 2022.

Unisys Corp. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Retrieved on: 
Wednesday, November 9, 2022
Unisys, GLOBE, Audit, NYSE, Director, Disclosure, Company, Committee on Finance, UIS, Security (finance)

BOSTON, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Unisys Corp. (NYSE: UIS) for potential securities law violations.

Key Points: 
  • BOSTON, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Unisys Corp. (NYSE: UIS) for potential securities law violations.
  • Investors who have lost money in their Unisys Corp. investment should contact the firm to learn more about how they might recover those losses.
  • Anyone who purchased Unisys Corp. stock and has lost money may be eligible, whether or not they have sold their investment.
  • Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money.

Patriot Battery Metals Lodges ASX Prospectus

Retrieved on: 
Wednesday, November 9, 2022
Lithium, Director, GLOBE, Property, CDI, Forward-looking statement, CV5, CHESS, Prospectus, Board, FSE, News, Company, Offering, Trans-Taiga Road, ASX, AUD, Pontax River, Ownership, Acquisition, AGM, NWT, QC

VANCOUVER, British Columbia, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Patriot Battery Metals Inc. (the Company or Patriot) (TSX-V: PMET) (OTCQB: PMETF) (FSE: R9GA) is pleased to provide an update in relation to the Companys planned ASX listing.

Key Points: 
  • VANCOUVER, British Columbia, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Patriot Battery Metals Inc. (the Company or Patriot) (TSX-V: PMET) (OTCQB: PMETF) (FSE: R9GA) is pleased to provide an update in relation to the Companys planned ASX listing.
  • The Company has lodged a prospectus today in Australia (November 9, 2022) to raise AUD $4.2m (the Offering) to support an application to list on the ASX.
  • The Offering is scheduled to formally open on November 16, 2023 and is expected to close on November 21, 2022.
  • About Patriot Battery Metals Inc.
    Patriot Battery Metals Inc. is a mineral exploration company focused on the acquisition and development of mineral properties containing battery, base, and precious metals.

Stella-Jones Delivers Robust Third Quarter Results

Retrieved on: 
Wednesday, November 9, 2022
Director, ESG, Stella Jones (writer), Toronto Stock Exchange, Webcast, Notice of Intent to Revoke, Intention, SJ, Board, Interest, Wood, Legislation, Suite, Mission statement, Coronavirus, Achievement, Public expenditure, WOOD, Time, EBITDA, Company, Maintenance, Transport, Growth, Coal, TSX, Acquisition, Income, Security (finance), Lumber, Renewable energy, Retail

During the third quarter of 2022, the continued growth in maintenance and project-related demand was offset in large part by lower volumes for fire-resistant wrapped poles.

Key Points: 
  • During the third quarter of 2022, the continued growth in maintenance and project-related demand was offset in large part by lower volumes for fire-resistant wrapped poles.
  • Residential lumber (27% of Q3-22 sales): Residential lumber sales totaled $226 million in the third quarter of 2022, up from $170 million in the third quarter of 2021.
  • Gross profit was $139 million in the third quarter of 2022, versus $82 million, in the third quarter of 2021, representing a margin of 16.5% and 12.1% respectively.
  • As a result, readers are advised that actual results may differ from expected results.

Karat Packaging Declares Special Dividend of $0.35 Per Share

Retrieved on: 
Wednesday, November 9, 2022
Director, GLOBE, Private Securities Litigation Reform Act, Risk, U.S. Securities and Exchange Commission, KRT, Board, SEC, Annual report, Printing, Drug Master File, Security (finance), Food

CHINO, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Karat Packaging Inc. (Nasdaq: KRT) (the Company or Karat), a specialty distributor and manufacturer of environmentally friendly, disposable foodservice products and related items, today announced that the Board of Directors has declared a special dividend of $0.35 per share on the Companys common stock.

Key Points: 
  • CHINO, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Karat Packaging Inc. (Nasdaq: KRT) (the Company or Karat), a specialty distributor and manufacturer of environmentally friendly, disposable foodservice products and related items, today announced that the Board of Directors has declared a special dividend of $0.35 per share on the Companys common stock.
  • The special dividend is payable on or around November 30, 2022 to shareholders of record at the close of business on November 21, 2022.
  • Alan Yu, Chairman and Chief Executive Officer, said, The special dividend reflects our Boards confidence in Karats business over the long-term and the Companys positive cash flow performance.
  • Karat Packaging also offers customized solutions, including new product development and design, printing, and logistics services.

KP Tissue declares a Quarterly Dividend of $0.18 per Common Share

Retrieved on: 
Wednesday, November 9, 2022
Director, GLOBE, Review, NOT, FOR, Indian stock exchange, WIRE, Partnership, Plan, Board, Interest, Income Tax Act, COC, KPT, Food away from home, Dividend, DRIP, Corporation, TSX, Income Tax Act 2007, White, Holding company, Security (finance), U.S.A

MISSISSAUGA, Ontario, Nov. 09, 2022 (GLOBE NEWSWIRE) -- KP Tissue Inc. (“KPT”) (TSX: KPT) announced today that the Board of Directors has declared a quarterly dividend of $0.18 per common share, payable on January 16, 2023 to shareholders of record at the close of business on December 31, 2022, subject to applicable law.

Key Points: 
  • The dividend is being declared in connection with the declaration of a corresponding quarterly distribution by Kruger Products L.P. (KPLP) in which KP Tissue holds a limited partnership interest.
  • The Corporation has a Dividend Reinvestment Plan under which eligible shareholders may elect to have their cash dividends reinvested in additional common shares of KPT.
  • Under the Plan, the Corporation will automatically reinvest for participating shareholders the cash dividends of KPT in newly issued Common Shares at a price per Common Share equal to 100% of the 5-day weighted average trading price of the Common Shares prior to the dividend payment date.
  • Only Canadian shareholders are eligible to participate in the DRIP and the DRIP is subject to additional limitations and restrictions.